Fierce Pharma

JULY 19, 2024

While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at hospitals, the experience from the meltdown | While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at hospitals, the experience from the meltdown appeared different among large pharma companies.

Pharma 285

Pharma 285

MedCity News

JULY 19, 2024

A new eBook from MedCity News highlights the variety of technologies emerging from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant. It also explores the ethical issues AI in healthcare presents. The post The Shifting AI Landscape appeared first on MedCity News.

Ethics 113

Ethics Biopharma Healthcare Healthcare 113

Fierce Pharma

JULY 19, 2024

A 10-page Form 483 has detailed the shortfalls at Hengrui Pharma's PD-1 plant behind a recent FDA rejection. Sanofi is investing heavily to expand its global capacity center in India. | A 10-observation Form 483 has detailed the shortfalls at Hengrui Pharma's PD-1 plant behind its recent FDA rejection. Sanofi is investing heavily to expand its global capacity center in India.

Pharma 246

Pharma FDA 246

Pharmaceutical Commerce

JULY 19, 2024

FDA to review one-year results for Susvimo showing non-inferior visual acuity gains in diabetic macular edema and in the Diabetic Retinopathy Severity Scale for Diabetic Retinopathy.

FDA 104

FDA Patients 104

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Fierce Pharma

JULY 19, 2024

Back in February, Novo Holdings laid out a $16.5 billion deal to snap up contract manufacturing giant Catalent. | In February, Novo Holdings announced a $16.5 billion deal to acquire Catalent, and this week on "The Top Line," we explore the current state and implications of the proposed buyout.

Manufacturing 246

Manufacturing 246

pharmaphorum

JULY 19, 2024

FDA will create a rare disease hub to speed the development of new treatments and build connections between developers and the rare disease community

FDA 113

FDA 113

MedCity News

JULY 19, 2024

An opportunity for children to learn and grow in a supportive environment that prioritizes personalized treatment and transparent care The post Industry Review: ABA Therapy and Why It Is One of the Best Therapy Options for Children With Autism appeared first on MedCity News.

Patients 106

Patients 106

pharmaphorum

JULY 19, 2024

While the pace of biotech private rounds seems to have slowed a little of late, this week saw four big financings for Cardurion Pharma, Scorpion Therapeutics, CatalYm, and NGM Bio.Burlington, Massachusetts-based Cardurion led the quartet with a $260 million Series B for its heart-focused drug pipeline, which features two candidates in phase 2 testing – PDE9 inhibitor CRD-750 for heart failure and CaMKII inhibitor CRD-4730 for rare genetic disease catecholaminergic polymorphic ventricular tachyca

Pharma 102

Pharma 102

MedCity News

JULY 19, 2024

The integration of AI and human skills is poised to revolutionize surgical practices. The post Proprioceptive Precision: Transforming Surgery Through AI and Human Expertise appeared first on MedCity News.

106

106

pharmaphorum

JULY 19, 2024

Less than two years after pulling multiple myeloma therapy Blenrep off most markets around the world, GSK has filed for approval of the drug in the EU once again, hoping to restore its blockbuster credentials.The remarkable renaissance for the BCMA-directed antibody-drug conjugate is supported by a pair of phase 3 trials that could not only support its return but also make it an option for a much larger patient population than before.

Marketing 101

Marketing Patients 101

Advertisement

MedCity News

JULY 19, 2024

Harvard spinout GRO Biosciences has a platform technology for engineering therapeutic proteins that won’t prompt an immune response against them. The startup’s lead program is a potential competitor to an Amgen gout drug acquired in a multi-billion dollar deal. The post Aiming to Top Amgen in Gout, Startup GRObio Gets $60M to Enter the Clinic appeared first on MedCity News.

Engineering 109

Engineering Leads Biopharma 109

pharmaphorum

JULY 19, 2024

NICE backs NHS use of Accord's Orgovyx, the first therapy for advanced hormone-sensitive prostate cancer that can be taken at home

104

104

MedCity News

JULY 19, 2024

Profound opportunities and challenges are playing out at the intersection of the two. The post Policy Innovation Is Outpacing Technology at the Intersection of Health Care and Human Services appeared first on MedCity News.

108

108

PharmaTimes

JULY 19, 2024

LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia

107

107

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales

MedCity News

JULY 19, 2024

Boehringer’s adalimumab-adbm is being offered on GoodRx’s platform for $550 per two-pack, a 92% discount from the Humira list price, according to the companies. The post GoodRx, Boehringer Ingelheim Launch Initiative for Humira Biosimilar appeared first on MedCity News.

104

104

PharmaTimes

JULY 19, 2024

Chronic pelvic pain is a disabling condition that affects around one in four women worldwide

Medicine 92

Medicine 92

MedCity News

JULY 19, 2024

In one of the only pieces of health policy in the GOP’s 2024 platform, the former president vows not to cut Social Security or Medicare, the health program for older and disabled Americans, or change the federal retirement age. The post At the GOP Convention, There’s Little To Be Heard on Healthcare appeared first on MedCity News.

Healthcare 98

Healthcare Healthcare 98

PharmaVoice

JULY 19, 2024

The pharma company is tackling the “stiff person syndrome” that afflicts Celine Dion in a phase 2 trial for its lead CAR-T candidate.

Pharma 69

Pharma Leads 69

Advertisement

Distribution

PharmaTimes

JULY 19, 2024

Accreditation recognises 'continued professional development' opportunities

89

89

European Pharmaceutical Review

JULY 19, 2024

This report delves into the latest advances and developments impacting pharmaceutical drug formulators today. Inside, articles explore current vast expansion of the formulation including patient centricity, excipients, safety, quality and regulatory considerations. Stay up to date with the latest developments in drug formulation including articles on: The trends and challenges for OSD and patient centric formulations Cell and gene therapy formulation including the prominent issues and opportunit

Pharma 59

Pharma Manufacturing Pharmaceutical Safety 59

Clarivate

JULY 19, 2024

The Unitary Patent Court (UPC) has emerged as a new force in the global patent landscape. For the first time, it offers a means to enforce patents across 17 European states, creating an environment capable of rivaling other major global patent jurisdictions. The UPC aims to deliver highly effective relief to plaintiffs in terms of speed-to-decision, proportionality and cost.

Engineering 59

Engineering 59

PharmaVoice

JULY 19, 2024

Merdad Parsey joined Gilead as its chief medical officer in 2019 and has helped lead the company’s expansion into oncology, with mixed success.

Leads 59

Leads Medical 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

European Pharmaceutical Review

JULY 19, 2024

Nathalie Moll, Director General, the European Federation of Pharmaceutical Industries and Associations (EFPIA), has commended inclusion of a “dedicated life sciences strategy” in the Political Guidelines for the Next European Commission 2024-2029. The proposed guidelines were presented to the European Parliament by President-elect of the European Commission (2024-2029), Ursula von der Leyen.

Competition 52

Competition Medicine Pharmaceutical Manufacturing 52

eMediWrite

JULY 19, 2024

Establish Distinct Brand Identity : Create a distinct identity for your pharmaceutical brand that encompasses your values, mission, and USPs. Make sure that the brand’s messaging is consistent throughout all media. Tap Into Your Target Group : Your target group has wants, interests, and habits which should be fully capitalised through market research.

Education 52

Education Competition Pharma Media 52

Pharmaceutical Commerce

JULY 19, 2024

In an interview with Pharma Commerce editor Nicholas Saraceno, Matthew Walsh, ixlayer’s manager of biopharma, dives into efficiencies presented by at-home diagnostic tests.

Physicians 52

Physicians Biopharma Pharma Management 52

Pharmaceutical Technology

JULY 19, 2024

New global projections and advances in HIV therapies are also on the agenda at the 25th International AIDS 2024 meeting.

Patients 64

Patients 64

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmExec

JULY 19, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

Copyright Clearance Center

JULY 19, 2024

Copyright Clearance Center (CCC) has launched a collective licensing solution for the internal use of copyrighted materials in AI systems.

52

52

PharmExec

JULY 19, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Medical 52

Medical 52

Pharmaceutical Technology

JULY 19, 2024

Meitheal Pharmaceuticals has gained rights to CONTEPO (fosfomycin for injection) from Nabriva Therapeutics for the North American region.

Pharmaceutical 52

Pharmaceutical 52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety